Document is current
Any future updates will be listed below
-
Authors
Hurlburt, Nicholas K. https://orcid.org/0000-0001-9891-916X
Seydoux, Emilie
Wan, Yu-Hsin
Edara, Venkata Viswanadh
Stuart, Andrew B.
Feng, Junli
Suthar, Mehul S.
McGuire, Andrew T. https://orcid.org/0000-0003-1841-6859
Stamatatos, Leonidas
Pancera, Marie https://orcid.org/0000-0001-9217-6270
-
Funding
Funding for this research was provided by:
Fred Hutchinson Cancer Research Center
- License Information
-
More Information
Article History
Received: 15 June 2020
Accepted: 29 September 2020
First Online: 27 October 2020
Competing interests
: The authors declare no competing interests. A provisional patent application (U.S. Provisional Application number 63/016268) has been filed on the SARS-CoV-2-specific monoclonal antibodies isolated herein.
